D. E. Shaw & Co., Inc.

Position in MGTX — MeiraGTx Holdings plc

CIK 1009207 New York, NY

Position in MGTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,522,705

+$7,839,772 QoQ

Shares Held

852,902

+100.6% QoQ

Ownership

0.888%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#17

of 156 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. MGTX ranks #69 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,877,959	$626,707,987
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,104,109	$332,369,932
3	EXEL	Exelixis, Inc.	5,551,747	$302,070,554
4	BBIO	BridgeBio Pharma, Inc.	3,633,007	$270,586,360
5	TGTX	Tg Therapeutics, Inc.	3,400,808	$186,840,390
6	HALO	Halozyme Therapeutics, Inc.	2,006,479	$157,047,110
7	AXSM	Axsome Therapeutics, Inc.	604,753	$148,025,391
8	PTCT	Ptc Therapeutics, Inc.	1,548,919	$126,345,322

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,522,705	852,902	+100.6%	Shares	Defined	2026-08-14
2026-03-31	$3,682,933	425,281	+11.4%	Shares	Defined	2026-05-15
2025-12-31	$3,035,015	381,763	+120.4%	Shares	Defined	2026-02-17
2025-09-30	$1,425,451	173,202	+286.5%	Shares	Defined	2025-11-14
2025-03-31	$303,818	44,811	-63.8%	Shares	Defined	2025-05-15
2024-12-31	$752,985	123,643	+41.1%	Shares	Defined	2025-02-14
2024-09-30	$365,437	87,635	+26.8%	Shares	Defined	2024-11-14
2024-06-30	$290,944	69,108	+0.5%	Shares	Defined	2024-08-14
2024-03-31	$417,555	68,790	+88.0%	Shares	Defined	2024-05-15
2023-12-31	$256,819	36,584	+250.0%	Shares	Defined	2024-02-14
2020-06-30	$130,884	10,454	0.0%	Shares	Defined	2020-08-14
2020-03-31	$140,501	10,454	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.